Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease-Reference-Cited by-同舟云学术

Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease

Published:2016-07 Issue: Volume:281 Page:81-92
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Linares Gabriel R.,Chiu Chi-Tso,Scheuing Lisa,Leng Yan,Liao Hsiao-Mei,Maric Dragan,Chuang De-Maw

Funder

National Institute of Mental Health

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference55 articles.

1. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors;Balyasnikova;Mol. Ther.,2014

2. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease;Bhatt;Drug Deliv.,2015

3. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice;Boudreau;Mol. Ther.,2009

4. Current therapeutic advances in patients and experimental models of Huntington's disease;Brett;Curr. Drug Targets,2014

5. Intranasal treatment of central nervous system dysfunction in humans;Chapman;Pharm. Res.,2013

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in nanotherapeutic strategies for Huntington's disease: Design, delivery, and neuroprotective mechanisms;Coordination Chemistry Reviews;2025-01

2. Preconditioning of Human Umbilical Cord Mesenchymal Stem Cells with a Histone Deacetylase Inhibitor: Valproic Acid;Balkan Medical Journal;2024-09-06

3. Dimethyl Fumarate Preconditioning can Reinforce the Therapeutic Potential of Bone Marrow Mesenchymal Stem Cells through Trophic Factor Profile Enhancement;Advanced Biomedical Research;2024-05

4. Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes;Cells;2024-03-07

5. Secretome as a Tool to Treat Neurological Conditions: Are We Ready?;International Journal of Molecular Sciences;2023-11-20